pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-548w |
Genomic Coordinates | chr16: 26025237 - 26025310 |
Description | Homo sapiens miR-548w stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-548w | |||||||||||||||||||||||||||||||||
Sequence | 10| AAAAGUAACUGCGGUUUUUGCCU |32 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CBX3 | ||||||||||||||||||||
Synonyms | HECH, HP1-GAMMA, HP1Hs-gamma | ||||||||||||||||||||
Description | chromobox 3 | ||||||||||||||||||||
Transcript | NM_007276 | ||||||||||||||||||||
Other Transcripts | NM_016587 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CBX3 | |||||||||||||||||||||
3'UTR of CBX3 (miRNA target sites are highlighted) |
>CBX3|NM_007276|3'UTR 1 TTGTTCACATTGTTCTTTTATATATATTTATATATATATATAAAAATTGGGTCTTAGATTTTGATTTACTAGTGTGACAA 81 AATAACTACATCCTAATGAAAATCAAGTTTGATATGTTTGTTTTGAAAGTAGCGTTGGAAGAGTTGTTGGGGGTTTTTTG 161 CATCCATAGCACTGGTTACTTTGAACAAATAAATAAAAGCTTTCTGTAGTTGCTTCCTTTATCAGAAAAGAACATTTGAT 241 ACCATGGTATATCATTTCCTCTTCATTAAAGAACAGCTTTTCTAAATGTTGGGGGAAATGTCCATAGTCATTACTCAGTC 321 AAAACTTGTGTTCTCATGAGCCTAAGGACCATTCTAGATTTATTACGTGTTTTTTGTGTGTGTGTGTGTGTGTGTGTGTG 401 TGTGTATCCATAAAATGCATATGTAAATTTTTTTTTGTTTTTAAGCATTCACCCAAACAAAAAAATCACAGGTAAACCCA 481 TGTTTCTGAGATGCCATTATTCCAAGCAAAATAAGAGATAATCCCTTCAAGTTAAATTGAAAATTTTCCTGAAACCATAC 561 ATTTCAAGTGAAATAAGTAATTCTAGATAGGACAATTTAAATTGGATAATTTTAAAGTGTCTATAATTGCAGTGGTTTAT 641 TTGCAAAATTCCTAAAAGGAAAAATTTTATCACTGCCATCACAGCAGGTTTCCTCATCCAGATGAGGAAACTAGACAAAT 721 GCTAGTGTGTTTTAACTAGCTAAACAAAACTAAGTTAAATGAACATTTAAAAGTTTCCCTAGCGGGCCATTCCTTAGCAA 801 AATGTTGGAATCCCTGTTGCTACATTGACTAAAAGGTCATGATGAATGGAATATGTAAGACTTGGCTCATAGAAACCTAA 881 TCAGATGGTTAGAGGTGTTGGCAGTTTAGGACCTGCTGTCATAAATGTGTGAACAACCTTTTGTAACCTAACCTATTGAC 961 CTGCATGTTTTTTCTTTACCCCAATTCATTACATGGAGGCTCAATCTTGAGTTTGCTTTACTGGTTCAGCAAAAGCCAGG 1041 AAGAACAACTTTGTAGTAATCAAAATGTTATCCAACTGTATATTGTTTACTTTATTGTAAATACTGGTGAACAGTGGTTA 1121 ATAAATAGTTTTATATTCCTTTATGCAATTATTAGACTTTTTTCTTTATTTGATATGCCTTTACAGTAGAAATAGAAATG 1201 CCCACACTCATTGGATTATCTTTGTTTATAAGTTAGATGATACCAGTAAGGCATTACAGTACATATCCTAGATCTTTTGA 1281 GCTTACGAGTTTTAAACTTGAATATGTATTTCCACAGGAATGTTTCCACAGTTGGGAAATAAAAGTTTCATGTGATGCCT 1361 AGGGTCAATTGTCTCATTAAAATGAGGTTTTAAATTCTG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HCT116 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760632. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000337620.4 | 3UTR | CAUCCAUAGCACUGGUUACUUUGAACAAAUAAAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
184 hsa-miR-548w Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT057125 | DDIT4 | DNA damage inducible transcript 4 | 2 | 4 | ||||||||
MIRT063369 | ETNK1 | ethanolamine kinase 1 | 2 | 2 | ||||||||
MIRT072492 | RAB8B | RAB8B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT082186 | ACTN4 | actinin alpha 4 | 2 | 6 | ||||||||
MIRT083033 | PTBP1 | polypyrimidine tract binding protein 1 | 2 | 2 | ||||||||
MIRT085188 | SLC5A3 | solute carrier family 5 member 3 | 2 | 4 | ||||||||
MIRT088905 | FOXN2 | forkhead box N2 | 2 | 4 | ||||||||
MIRT089494 | MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | 2 | 6 | ||||||||
MIRT092039 | ABHD5 | abhydrolase domain containing 5 | 2 | 2 | ||||||||
MIRT094685 | FEM1C | fem-1 homolog C | 2 | 2 | ||||||||
MIRT095393 | UBE2D2 | ubiquitin conjugating enzyme E2 D2 | 2 | 2 | ||||||||
MIRT096501 | BRIX1 | BRX1, biogenesis of ribosomes | 2 | 2 | ||||||||
MIRT101296 | FAM135A | family with sequence similarity 135 member A | 2 | 2 | ||||||||
MIRT103356 | CBX3 | chromobox 3 | 2 | 2 | ||||||||
MIRT103872 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT104334 | CLDN12 | claudin 12 | 2 | 2 | ||||||||
MIRT104501 | PEG10 | paternally expressed 10 | 2 | 6 | ||||||||
MIRT111795 | MPZL1 | myelin protein zero like 1 | 2 | 2 | ||||||||
MIRT177238 | BMI1 | BMI1 proto-oncogene, polycomb ring finger | 2 | 2 | ||||||||
MIRT177273 | COMMD3-BMI1 | COMMD3-BMI1 readthrough | 2 | 2 | ||||||||
MIRT177626 | UBE2D1 | ubiquitin conjugating enzyme E2 D1 | 2 | 6 | ||||||||
MIRT178042 | SAMD8 | sterile alpha motif domain containing 8 | 2 | 2 | ||||||||
MIRT179102 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | 2 | 6 | ||||||||
MIRT179587 | CAPZA1 | capping actin protein of muscle Z-line alpha subunit 1 | 2 | 6 | ||||||||
MIRT195299 | LEPROT | leptin receptor overlapping transcript | 2 | 2 | ||||||||
MIRT203143 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT208430 | ZBTB38 | zinc finger and BTB domain containing 38 | 2 | 2 | ||||||||
MIRT214578 | SMAD5 | SMAD family member 5 | 2 | 4 | ||||||||
MIRT216103 | IL6ST | interleukin 6 signal transducer | 2 | 2 | ||||||||
MIRT216355 | CCNB1 | cyclin B1 | 2 | 4 | ||||||||
MIRT220050 | MDFIC | MyoD family inhibitor domain containing | 2 | 2 | ||||||||
MIRT226729 | ANP32B | acidic nuclear phosphoprotein 32 family member B | 2 | 4 | ||||||||
MIRT227698 | TBC1D13 | TBC1 domain family member 13 | 2 | 2 | ||||||||
MIRT230071 | SH3BGRL | SH3 domain binding glutamate rich protein like | 2 | 2 | ||||||||
MIRT248637 | HMGN2 | high mobility group nucleosomal binding domain 2 | 2 | 4 | ||||||||
MIRT254790 | XRCC6 | X-ray repair cross complementing 6 | 2 | 6 | ||||||||
MIRT264376 | YAP1 | Yes associated protein 1 | 2 | 2 | ||||||||
MIRT266972 | LRRC55 | leucine rich repeat containing 55 | 2 | 4 | ||||||||
MIRT273949 | SPRYD4 | SPRY domain containing 4 | 2 | 2 | ||||||||
MIRT281802 | MAP2K1 | mitogen-activated protein kinase kinase 1 | 2 | 2 | ||||||||
MIRT293252 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT297097 | RGPD4 | RANBP2-like and GRIP domain containing 4 | 2 | 2 | ||||||||
MIRT308170 | PDE12 | phosphodiesterase 12 | 2 | 2 | ||||||||
MIRT309013 | USP53 | ubiquitin specific peptidase 53 | 2 | 2 | ||||||||
MIRT311470 | PRRC1 | proline rich coiled-coil 1 | 2 | 2 | ||||||||
MIRT312586 | G3BP1 | G3BP stress granule assembly factor 1 | 2 | 4 | ||||||||
MIRT328130 | ZNF711 | zinc finger protein 711 | 2 | 2 | ||||||||
MIRT329313 | FAM53C | family with sequence similarity 53 member C | 2 | 2 | ||||||||
MIRT334642 | NEK7 | NIMA related kinase 7 | 2 | 2 | ||||||||
MIRT340673 | THRAP3 | thyroid hormone receptor associated protein 3 | 2 | 2 | ||||||||
MIRT378858 | ITGB8 | integrin subunit beta 8 | 2 | 2 | ||||||||
MIRT395789 | SPCS3 | signal peptidase complex subunit 3 | 2 | 2 | ||||||||
MIRT405639 | WBP4 | WW domain binding protein 4 | 2 | 4 | ||||||||
MIRT408287 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 2 | ||||||||
MIRT442097 | ZNRF2 | zinc and ring finger 2 | 2 | 8 | ||||||||
MIRT442840 | GTF2H5 | general transcription factor IIH subunit 5 | 2 | 2 | ||||||||
MIRT443116 | VLDLR | very low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT443147 | ZDHHC21 | zinc finger DHHC-type containing 21 | 2 | 2 | ||||||||
MIRT443298 | PRPS1L1 | phosphoribosyl pyrophosphate synthetase 1-like 1 | 2 | 2 | ||||||||
MIRT445080 | ZNF207 | zinc finger protein 207 | 2 | 2 | ||||||||
MIRT445384 | PTCHD1 | patched domain containing 1 | 2 | 4 | ||||||||
MIRT447070 | MCC | mutated in colorectal cancers | 2 | 2 | ||||||||
MIRT447300 | ZNF562 | zinc finger protein 562 | 2 | 2 | ||||||||
MIRT447512 | MRPS5 | mitochondrial ribosomal protein S5 | 2 | 2 | ||||||||
MIRT449511 | TM6SF1 | transmembrane 6 superfamily member 1 | 2 | 2 | ||||||||
MIRT449902 | C11orf34 | placenta expressed transcript 1 | 1 | 2 | ||||||||
MIRT450551 | SHFM1 | SEM1, 26S proteasome complex subunit | 2 | 2 | ||||||||
MIRT450719 | PVRL3 | nectin cell adhesion molecule 3 | 2 | 2 | ||||||||
MIRT454923 | ANKEF1 | ankyrin repeat and EF-hand domain containing 1 | 2 | 12 | ||||||||
MIRT455892 | KIF2C | kinesin family member 2C | 2 | 2 | ||||||||
MIRT463732 | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 2 | 8 | ||||||||
MIRT471182 | PHB2 | prohibitin 2 | 2 | 2 | ||||||||
MIRT472764 | MTMR6 | myotubularin related protein 6 | 2 | 8 | ||||||||
MIRT474457 | KLHL11 | kelch like family member 11 | 2 | 8 | ||||||||
MIRT475985 | GTPBP2 | GTP binding protein 2 | 2 | 2 | ||||||||
MIRT482277 | AGO2 | argonaute 2, RISC catalytic component | 2 | 4 | ||||||||
MIRT485858 | ALG9 | ALG9, alpha-1,2-mannosyltransferase | 2 | 2 | ||||||||
MIRT486192 | ERH | ERH, mRNA splicing and mitosis factor | 2 | 4 | ||||||||
MIRT488609 | FAM3C | family with sequence similarity 3 member C | 2 | 6 | ||||||||
MIRT489984 | DDB1 | damage specific DNA binding protein 1 | 2 | 2 | ||||||||
MIRT493476 | IPMK | inositol polyphosphate multikinase | 2 | 2 | ||||||||
MIRT494280 | CEP120 | centrosomal protein 120 | 2 | 2 | ||||||||
MIRT497992 | ZBTB20 | zinc finger and BTB domain containing 20 | 2 | 2 | ||||||||
MIRT498473 | PTBP2 | polypyrimidine tract binding protein 2 | 2 | 10 | ||||||||
MIRT498559 | TMEM30B | transmembrane protein 30B | 2 | 2 | ||||||||
MIRT499867 | SVOP | SV2 related protein | 2 | 10 | ||||||||
MIRT500220 | INHBA | inhibin beta A subunit | 2 | 10 | ||||||||
MIRT500694 | TRIM37 | tripartite motif containing 37 | 2 | 2 | ||||||||
MIRT500988 | SPPL2A | signal peptide peptidase like 2A | 2 | 4 | ||||||||
MIRT501023 | SMG1 | SMG1, nonsense mediated mRNA decay associated PI3K related kinase | 2 | 6 | ||||||||
MIRT502736 | CLIP1 | CAP-Gly domain containing linker protein 1 | 2 | 8 | ||||||||
MIRT502798 | CELSR3 | cadherin EGF LAG seven-pass G-type receptor 3 | 2 | 6 | ||||||||
MIRT502887 | CDK4 | cyclin dependent kinase 4 | 2 | 8 | ||||||||
MIRT503483 | ZNF154 | zinc finger protein 154 | 2 | 6 | ||||||||
MIRT503717 | GRM5 | glutamate metabotropic receptor 5 | 2 | 2 | ||||||||
MIRT505137 | YOD1 | YOD1 deubiquitinase | 2 | 2 | ||||||||
MIRT505802 | RSBN1 | round spermatid basic protein 1 | 2 | 8 | ||||||||
MIRT505841 | POLR1B | RNA polymerase I subunit B | 2 | 4 | ||||||||
MIRT509284 | NPM3 | nucleophosmin/nucleoplasmin 3 | 2 | 6 | ||||||||
MIRT516829 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT520519 | TRA2B | transformer 2 beta homolog | 2 | 2 | ||||||||
MIRT520723 | TM9SF3 | transmembrane 9 superfamily member 3 | 2 | 6 | ||||||||
MIRT525403 | SHISA9 | shisa family member 9 | 2 | 4 | ||||||||
MIRT525867 | ARL13B | ADP ribosylation factor like GTPase 13B | 2 | 2 | ||||||||
MIRT526013 | RBM4B | RNA binding motif protein 4B | 2 | 2 | ||||||||
MIRT526084 | TMEM41B | transmembrane protein 41B | 2 | 2 | ||||||||
MIRT527931 | FRY | FRY microtubule binding protein | 2 | 2 | ||||||||
MIRT528818 | RAB32 | RAB32, member RAS oncogene family | 2 | 2 | ||||||||
MIRT531062 | SLC9A4 | solute carrier family 9 member A4 | 2 | 4 | ||||||||
MIRT535495 | PANX1 | pannexin 1 | 2 | 2 | ||||||||
MIRT536682 | IKZF5 | IKAROS family zinc finger 5 | 2 | 2 | ||||||||
MIRT536835 | HMBOX1 | homeobox containing 1 | 2 | 2 | ||||||||
MIRT537202 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 4 | ||||||||
MIRT537834 | EFNA5 | ephrin A5 | 2 | 2 | ||||||||
MIRT538345 | CSE1L | chromosome segregation 1 like | 2 | 4 | ||||||||
MIRT541242 | GPC4 | glypican 4 | 2 | 2 | ||||||||
MIRT543235 | PEX7 | peroxisomal biogenesis factor 7 | 2 | 2 | ||||||||
MIRT543450 | PARP15 | poly(ADP-ribose) polymerase family member 15 | 2 | 2 | ||||||||
MIRT543711 | XKR9 | XK related 9 | 2 | 2 | ||||||||
MIRT543907 | ESYT1 | extended synaptotagmin 1 | 2 | 2 | ||||||||
MIRT543999 | KLRC3 | killer cell lectin like receptor C3 | 2 | 2 | ||||||||
MIRT544070 | METTL8 | methyltransferase like 8 | 2 | 2 | ||||||||
MIRT544187 | ANGPTL3 | angiopoietin like 3 | 2 | 2 | ||||||||
MIRT544808 | ACSM2B | acyl-CoA synthetase medium chain family member 2B | 2 | 2 | ||||||||
MIRT545046 | PRELID1 | PRELI domain containing 1 | 2 | 2 | ||||||||
MIRT545214 | HIST1H2BD | histone cluster 1 H2B family member d | 2 | 2 | ||||||||
MIRT545289 | SPC25 | SPC25, NDC80 kinetochore complex component | 2 | 2 | ||||||||
MIRT545550 | GIMAP4 | GTPase, IMAP family member 4 | 2 | 2 | ||||||||
MIRT546497 | SIK1 | salt inducible kinase 1 | 2 | 2 | ||||||||
MIRT546914 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT547675 | KPNA1 | karyopherin subunit alpha 1 | 2 | 4 | ||||||||
MIRT547770 | KATNAL1 | katanin catalytic subunit A1 like 1 | 2 | 2 | ||||||||
MIRT548687 | CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 2 | 2 | ||||||||
MIRT548901 | CHEK2 | checkpoint kinase 2 | 2 | 4 | ||||||||
MIRT549957 | RPL7L1 | ribosomal protein L7 like 1 | 2 | 4 | ||||||||
MIRT550489 | TMEM241 | transmembrane protein 241 | 2 | 2 | ||||||||
MIRT551049 | MKLN1 | muskelin 1 | 2 | 2 | ||||||||
MIRT552811 | XIAP | X-linked inhibitor of apoptosis | 2 | 4 | ||||||||
MIRT553145 | UBE2H | ubiquitin conjugating enzyme E2 H | 2 | 2 | ||||||||
MIRT553830 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | 2 | 2 | ||||||||
MIRT554258 | SIX4 | SIX homeobox 4 | 2 | 2 | ||||||||
MIRT555781 | PCMTD1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 | 2 | 2 | ||||||||
MIRT556318 | MAP2K4 | mitogen-activated protein kinase kinase 4 | 2 | 2 | ||||||||
MIRT556499 | LIPA | lipase A, lysosomal acid type | 2 | 2 | ||||||||
MIRT556693 | KLHL28 | kelch like family member 28 | 2 | 2 | ||||||||
MIRT556752 | KLF7 | Kruppel like factor 7 | 2 | 2 | ||||||||
MIRT556990 | HPRT1 | hypoxanthine phosphoribosyltransferase 1 | 2 | 2 | ||||||||
MIRT557146 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT557487 | GPR27 | G protein-coupled receptor 27 | 2 | 4 | ||||||||
MIRT558102 | ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | 2 | 2 | ||||||||
MIRT559344 | ATP5G3 | ATP synthase, H+ transporting, mitochondrial Fo complex subunit C3 (subunit 9) | 2 | 2 | ||||||||
MIRT560335 | ZWINT | ZW10 interacting kinetochore protein | 2 | 2 | ||||||||
MIRT561299 | ZBTB43 | zinc finger and BTB domain containing 43 | 2 | 2 | ||||||||
MIRT561883 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 2 | 2 | ||||||||
MIRT561927 | MFSD9 | major facilitator superfamily domain containing 9 | 2 | 2 | ||||||||
MIRT562935 | TNIP2 | TNFAIP3 interacting protein 2 | 2 | 2 | ||||||||
MIRT563291 | BBS10 | Bardet-Biedl syndrome 10 | 2 | 2 | ||||||||
MIRT563405 | KIF3A | kinesin family member 3A | 2 | 2 | ||||||||
MIRT563562 | KIAA1586 | KIAA1586 | 2 | 2 | ||||||||
MIRT565876 | NHS | NHS actin remodeling regulator | 2 | 2 | ||||||||
MIRT566081 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT566396 | PLAGL2 | PLAG1 like zinc finger 2 | 2 | 2 | ||||||||
MIRT567259 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | 2 | 2 | ||||||||
MIRT571468 | CCDC80 | coiled-coil domain containing 80 | 2 | 2 | ||||||||
MIRT572939 | VDAC2 | voltage dependent anion channel 2 | 2 | 2 | ||||||||
MIRT573628 | ZNF724P | zinc finger protein 724 | 2 | 2 | ||||||||
MIRT573717 | KHSRP | KH-type splicing regulatory protein | 2 | 2 | ||||||||
MIRT609088 | SMIM15 | small integral membrane protein 15 | 2 | 6 | ||||||||
MIRT617936 | EBNA1BP2 | EBNA1 binding protein 2 | 2 | 2 | ||||||||
MIRT618379 | PRKG2 | protein kinase, cGMP-dependent, type II | 2 | 2 | ||||||||
MIRT619627 | PLEKHG7 | pleckstrin homology and RhoGEF domain containing G7 | 2 | 2 | ||||||||
MIRT623455 | KDM5A | lysine demethylase 5A | 2 | 2 | ||||||||
MIRT629145 | CTCFL | CCCTC-binding factor like | 2 | 2 | ||||||||
MIRT638521 | LYRM2 | LYR motif containing 2 | 2 | 2 | ||||||||
MIRT649483 | CLDN16 | claudin 16 | 2 | 2 | ||||||||
MIRT683148 | MTHFD1 | methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 | 2 | 2 | ||||||||
MIRT691660 | SLC43A3 | solute carrier family 43 member 3 | 2 | 2 | ||||||||
MIRT693201 | MKI67 | marker of proliferation Ki-67 | 2 | 2 | ||||||||
MIRT695334 | AQP3 | aquaporin 3 (Gill blood group) | 2 | 2 | ||||||||
MIRT701023 | PCGF5 | polycomb group ring finger 5 | 2 | 2 | ||||||||
MIRT708753 | RYBP | RING1 and YY1 binding protein | 2 | 2 | ||||||||
MIRT717558 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT719286 | SETD7 | SET domain containing lysine methyltransferase 7 | 2 | 2 | ||||||||
MIRT725172 | SDAD1 | SDA1 domain containing 1 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|